In addition, an additional 8 overlapping proteins have been suggested as potential biomarkers for pancreatic cancer (Hepatocyte growth factor (HGF), Interleukin 7 (IL-7), Cathepsin D (CTSD), Monocyte chemoattractant protein 1 (MCP-1), Interleukin-16 (IL-16), C-C motif chemokine 11 (CCL11), Osteoprotegerin (OPG) and Anterior gradient protein 2 homolog (AGR2)) [31,32,33,34,35]. The gene discussed is CCL2; the disease is familial pancreatic carcinoma.